Phosphorylation and Functions of the RNA Polymerase II CTD
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Active Site of the Mrna-Capping Enzyme Guanylyltransferase from Saccharomyces Cerevisiae
Proc. Nati. Acad. Sci. USA Vol. 91, pp. 6624-6628, July 1994 Biochemistry Active site of the mRNA-capping enzyme guanylyltransferase from Saccharomyces cerevisiae: Similarity to the nucleotidyl attachment motif of DNA and RNA ligases (nucleoidyl trnsfer/covalent catalysis) LUCILLE D. FRESCO* AND STEPHEN BURATOWSKI*t The Whitehead Institute for Biomedical Research, Nine Cambridge Center, Cambridge, MA 02142 Communicated by Phillip A. Sharp, March 8, 1994 ABSTRACT Nasent mRNAchains are capped atthe 5' end The covalent E-GMP intermediate (EnpG) can be conve- by the addiion ofa guanylyl residue to forma G(5')ppp(5')N... niently identified by radioactive labeling of the protein with structure. During the capping reaction, the guanylyltrnerase [a-32P]GTP. (GTP:mRNA guanylyltransferase, EC 2.7.7.50) is reversibly Interest in the mechanism ofcapping has focused attention and covalently guanylylated. In this enzyme-GMP (E-GMP) on the E-GMP complex. Cellular mRNA guanylyltrans- termediate, GMP Is linked to the E-amino group of a lysine ferases from human, rat liver, calf thymus, Artemia salina, residue via a phosphoamide bond. Lys-70 was Identid as the wheat germ, and Saccharomyces cerevisiae all form E-GMP GMP attachment ste of the Saccharomyces cerevisiae guanylyl- covalent complexes (reviewed in ref. 3). In addition, cyto- transferase (encoded by the CEGI gene) by guanyylpeptide plasmic viruses encode their own capping enzymes. The sequencing. CEGI genes with substitutions at Lys-70 were guanylyltransferases of vaccinia virus (12, 13), reovirus (11, unable to support viability in yeast and produced proteins that 14, 15), African swine fever virus (16), rotavirus (17), blue- were not guanylylated in vitro. -
Liver Med23 Ablation Improves Glucose and Lipid Metabolism Through Modulating FOXO1 Activity
Cell Research (2014) 24:1250-1265. npg © 2014 IBCB, SIBS, CAS All rights reserved 1001-0602/14 ORIGINAL ARTICLE www.nature.com/cr Liver Med23 ablation improves glucose and lipid metabolism through modulating FOXO1 activity Yajing Chu1, Leonardo Gómez Rosso1, Ping Huang2, Zhichao Wang1, Yichi Xu3, Xiao Yao1, Menghan Bao1, Jun Yan3, Haiyun Song2, Gang Wang1 1State Key Laboratory of Cell Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chi- nese Academy of Sciences, 320 Yueyang Road, Shanghai 200031, China; 2Key Laboratory of Nutrition and Metabolism, Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, 320 Yueyang Road, Shang- hai 200031, China; 3CAS-MPG Partner Institute for Computational Biology, Shanghai Institute for Biological Sciences, Chinese Academy of Sciences, 320 Yueyang Road, Shanghai 200031, China Mediator complex is a molecular hub integrating signaling, transcription factors, and RNA polymerase II (RNAPII) machinery. Mediator MED23 is involved in adipogenesis and smooth muscle cell differentiation, suggesting its role in energy homeostasis. Here, through the generation and analysis of a liver-specific Med23-knockout mouse, we found that liver Med23 deletion improved glucose and lipid metabolism, as well as insulin responsiveness, and prevented diet-induced obesity. Remarkably, acute hepatic Med23 knockdown in db/db mice significantly improved the lipid profile and glucose tolerance. Mechanistically, MED23 participates in gluconeogenesis and cholesterol synthesis through modulating the transcriptional activity of FOXO1, a key metabolic transcription factor. Indeed, hepatic Med23 deletion impaired the Mediator and RNAPII recruitment and attenuated the expression of FOXO1 target genes. Moreover, this functional interaction between FOXO1 and MED23 is evolutionarily conserved, as the in vivo activities of dFOXO in larval fat body and in adult wing can be partially blocked by Med23 knockdown in Drosophila. -
Yeast Genome Gazetteer P35-65
gazetteer Metabolism 35 tRNA modification mitochondrial transport amino-acid metabolism other tRNA-transcription activities vesicular transport (Golgi network, etc.) nitrogen and sulphur metabolism mRNA synthesis peroxisomal transport nucleotide metabolism mRNA processing (splicing) vacuolar transport phosphate metabolism mRNA processing (5’-end, 3’-end processing extracellular transport carbohydrate metabolism and mRNA degradation) cellular import lipid, fatty-acid and sterol metabolism other mRNA-transcription activities other intracellular-transport activities biosynthesis of vitamins, cofactors and RNA transport prosthetic groups other transcription activities Cellular organization and biogenesis 54 ionic homeostasis organization and biogenesis of cell wall and Protein synthesis 48 plasma membrane Energy 40 ribosomal proteins organization and biogenesis of glycolysis translation (initiation,elongation and cytoskeleton gluconeogenesis termination) organization and biogenesis of endoplasmic pentose-phosphate pathway translational control reticulum and Golgi tricarboxylic-acid pathway tRNA synthetases organization and biogenesis of chromosome respiration other protein-synthesis activities structure fermentation mitochondrial organization and biogenesis metabolism of energy reserves (glycogen Protein destination 49 peroxisomal organization and biogenesis and trehalose) protein folding and stabilization endosomal organization and biogenesis other energy-generation activities protein targeting, sorting and translocation vacuolar and lysosomal -
Sudips Revised Thesis
Investigation Of The Behavior Of The Gal4 Inhibitor Gal80 Of The GAL Genetic Switch In The Yeast Saccharomyces Cerevisiae Dissertation Presented in Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in the Graduate School of The Ohio State University By Sudip Goswami, M.S. Graduate Program in Molecular Genetics The Ohio State University 2014 Dissertation Committee Dr. James Hopper, Advisor Dr. Stephen Osmani Dr. Hay-Oak Park Dr. Jian-Qiu Wu ii Copyright by Sudip Goswami 2014 iii ABSTRACT The DNA-binding transcriptional activator Gal4 and its regulators Gal80 and Gal3 constitute a galactose-responsive switch for the GAL genes of Saccharomyces cerevisiae. Gal4 binds to upstream activation sequences or UASGAL sites on GAL gene promoters as a dimer both in the absence and presence of galactose. In the absence of galactose, a Gal80 dimer binds to and masKs the Gal4 activation domain, inhibiting its activity. In the presence of galactose, Gal3 interacts with Gal80 and relieves Gal80’s inhibition of Gal4 activity allowing rapid induction of expression of GAL genes. In the first part of this work (Chapter 2) in-vitro chemical crosslinking coupled with SDS PAGE and native PAGE analysis were employed to show that the presence of Gal3 that can interact with Gal80 impairs Gal80 self association. In addition, live cell spinning disK confocal imaging showed that dissipation of newly discovered Gal80-2mYFP/2GFP clusters in galactose is dependent on Gal3’s ability to interact with Gal80. In the second part (Chapter 3), extensive analysis of Gal80 clusters was carried out which showed that these clusters associate strongly with the GAL1-10-7 locus and this association is dependent on the presence of the UASGAL sites at this locus. -
Commentary a Positive Addition to a Negative Tail's Tale Arno L
Commentary A positive addition to a negative tail's tale Arno L. Greenleaf Biochemistry Department, Duke University Medical Center, Durham, NC 27710 The C-terminal repeat domain (CTD) of threonine hyperphosphorylation, this promoter-proximal paused complexes, the largest subunit ofRNA polymerase II modification produces a shift in SDS/gel thereby allowing productive elongation. is composed of multiple repeats of the mobility. In contrast to c-Abl, a different The presence of CTD kinase activity in consensus heptamer sequence Tyr-Ser- tyrosine kinase, c-Src, does not phos- preinitiation complexes and the apparent Pro-Thr-Ser-Pro-Ser (YSPTSPS in sin- phorylate the CTD in vitro. This addi- association of CTD kinase activity with gle-letter code) (for reviews, see refs. tional information forces a significant re- transcription factor TFIIH are consistent 1-3); thus five of the seven residues of evaluation of our ideas about CTD phos- with this suggestion (refs. 8-10 and the each repeat are potential sites of phos- phorylation. references therein). More recent in vivo phorylation. Indeed, hyperphosphoryla- One obvious question raised by these experiments are also in general agree- tion ofthis domain has been documented findings concerns the identity of the ty- ment with this overall picture (11). It in organisms from yeast to human (one rosine kinase(s) that phosphorylates the should be pointed out, however, that diagnostic for hyperphosphorylation of CTD in vivo. The previously known and despite the identification and character- the CTD is a marked mobility change of now reported properties ofc-Abl are con- ization of a number of different CTD the largest subunit in SDS gels; unphos- sistent with its playing such a role in the kinases, the identity of the kinase(s) act- phorylated subunit "IIa" migrates with nucleus, but additional tests will be re- ing on the CTD in vivo has not been an apparent molecular mass of -215 quired to test critically this possibility. -
Double-Stranded DNA Translocase Activity of Transcription Factor TFIIH and the Mechanism of RNA Polymerase II Open Complex Formation
Double-stranded DNA translocase activity of transcription factor TFIIH and the mechanism of RNA polymerase II open complex formation James Fishburna, Eric Tomkob, Eric Galburtb,1, and Steven Hahna,1 aDivision of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109; and bDepartment of Biochemistry and Molecular Biophysics, Washington University in St. Louis, St. Louis, MO 63110 Edited by Robert G. Roeder, The Rockefeller University, New York, NY, and approved February 24, 2015 (received for review September 12, 2014) Formation of the RNA polymerase II (Pol II) open complex (OC) re- downstream from the site of DNA unwinding in the OC (20–24). quires DNA unwinding mediated by the transcription factor Therefore, XPB/Ssl2 cannot function as a conventional helicase TFIIH helicase-related subunit XPB/Ssl2. Because XPB/Ssl2 binds to promote OC formation (20). Three models have been pro- DNA downstream from the location of DNA unwinding, it cannot posed to explain the role of XPB/Ssl2 in transcription. First, it function using a conventional helicase mechanism. Here we show was postulated that XPB acts as a molecular wrench, binding to that yeast TFIIH contains an Ssl2-dependent double-stranded DNA its site on downstream DNA and using its ATPase to rotate up- translocase activity. Ssl2 tracks along one DNA strand in the 5′ → stream DNA within the Pol II cleft (20). Because upstream DNA 3′ direction, implying it uses the nontemplate promoter strand to is constrained by TBP, TFIIB, and other factors, DNA rotation reel downstream DNA into the Pol II cleft, creating torsional strain could lead to DNA opening. -
Supplementary Information
Supplementary Information Table S1. Pathway analysis of the 1246 dwf1-specific differentially expressed genes. Fold Change Fold Change Fold Change Gene ID Description (dwf1/WT) (XL-5/WT) (XL-6/WT) Carbohydrate Metabolism Glycolysis/Gluconeogenesis POPTR_0008s11770.1 Glucose-6-phosphate isomerase −1.7382 0.512146 0.168727 POPTR_0001s47210.1 Fructose-bisphosphate aldolase, class I 1.599591 0.044778 0.18237 POPTR_0011s05190.3 Probable phosphoglycerate mutase −2.11069 −0.34562 −0.9738 POPTR_0012s01140.1 Pyruvate kinase −1.25054 0.074697 −0.16016 POPTR_0016s12760.1 Pyruvate decarboxylase 2.664081 0.021062 0.371969 POPTR_0012s08010.1 Aldehyde dehydrogenase (NAD+) −1.41556 0.479957 −0.21366 POPTR_0014s13710.1 Acetyl-CoA synthetase −1.337 0.154552 −0.26532 POPTR_0017s11660.1 Aldose 1-epimerase 2.770518 0.016874 0.73016 POPTR_0010s11970.1 Phosphoglucomutase −1.25266 −0.35581 0.074064 POPTR_0012s14030.1 Phosphoglucomutase −1.15872 −0.68468 −0.93596 POPTR_0002s10850.1 Phosphoenolpyruvate carboxykinase (ATP) 1.489119 0.967284 0.821559 Citrate cycle (TCA cycle) 2-Oxoglutarate dehydrogenase E2 component POPTR_0014s15280.1 −1.63733 0.076435 0.170827 (dihydrolipoamide succinyltransferase) POPTR_0002s26120.1 Succinyl-CoA synthetase β subunit −1.29244 −0.38517 −0.3497 POPTR_0007s12750.1 Succinate dehydrogenase (ubiquinone) flavoprotein subunit −1.83751 0.519356 0.309149 POPTR_0002s10850.1 Phosphoenolpyruvate carboxykinase (ATP) 1.489119 0.967284 0.821559 Pentose phosphate pathway POPTR_0008s11770.1 Glucose-6-phosphate isomerase −1.7382 0.512146 0.168727 POPTR_0013s00660.1 Glucose-6-phosphate 1-dehydrogenase −1.26949 −0.18314 0.374822 POPTR_0015s00960.1 6-Phosphogluconolactonase 2.022223 0.168877 0.971431 POPTR_0010s11970.1 Phosphoglucomutase −1.25266 −0.35581 0.074064 POPTR_0012s14030.1 Phosphoglucomutase −1.15872 −0.68468 −0.93596 POPTR_0001s47210.1 Fructose-bisphosphate aldolase, class I 1.599591 0.044778 0.18237 S2 Table S1. -
RNA Capping Gene Expression in General Eukaryote Gene Expression Is Regulated at Seven Levels
Modification and processing of eukaryotic pre-mRNAs RNA Capping Gene Expression in General Eukaryote gene expression is regulated at seven levels: 1. Transcription 2. RNA processing 3. mRNA transport 4. mRNA translation 5. mRNA degradation 6. Protein targeting 7. Protein degradation Each of these levels contains multiple steps, which are also subject of control and regulation Control vs. regulation The Long and Winding Road….. Processing of eukaryotic RNA polymerase II transcripts Steps in pre-mRNA processing i). Capping ii). Splicing iii). Cleavage and polyadenylation I. Capping II. Splicing a). Chemistry of mRNA splicing b). Donor and acceptor splice sites c). Spliceosome assembly and splice site recognition d). Small nuclear RNAs and RNPs e). Role of SR proteins in splicing f). Splicing regulation g). Alternative splicing h).Mutations that disrupt splicing i). AT-AC introns j). Trans splicing III. 3’ End Processing: Cleavage and Polyadenylation of Primary Transcripts Steps in mRNA processing (hnRNA is the precursor of mRNA) • capping (occurs co-transcriptionally) • cleavage and polyadenylation (forms the 3’ end) • splicing (occurs in the nucleus prior to transport) exon 1 intron 1 exon 2 Transcription of pre-mRNA and capping at the 5’ end cap Cleavage of the 3’ end and polyadenylation cap cap poly(A) Splicing to remove intron sequences cap poly(A) Transport of mature mRNA to the cytoplasm RNA capping 5’ cap 6 Most eukaryotic mRNAs contain a 5' cap of 7-methylguanosine 1 5 7 2 9 8 linked to the 5'-end of the mRNA in a novel 5', 5'-triphosphate linkage 3 4 This base is not encoded in the DNA template The cap may also have some additional modifications including: 1.Methyl groups at 2'-O position of the 1st and 2nd template encoded nucleotides No methyl at either 1st or 2nd template encoded nucleotides = Cap 0 Methyl at only 1st template encoded nucleotide = Cap 1 Methyl at both 1st and 2nd template encoded nucleotides = Cap 2 2.In some cases, if the 1st nucleotide is an adenine it may be methylated at N6 RNA capping Addition of the cap involves several step: 1. -
5'-Terminal Capping of RNA by Guanylyltransferase
Proc. Nati. Acad. Sci. USA Vol. 74, No. 9, pp. 3758-3761, September 1977 Biochemistry 5'-Terminal capping of RNA by guanylyltransferase from HeLa cell nuclei (mRNA/7-methylguanosine/RNA processing) CHA-MER WEI AND BERNARD MOSS Laboratory of Biology of Viruses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20014 Communicated by Robert P. Perry, June 24, 1977 ABSTRACT A soluble extract prepared from HeLa cell MATERIALS AND METHODS nuclei has been shown to catalyze the 5'-terminal modification Preparation of Guanylyltransferase from of RNA and synthetic polyribonucleotides to form m7G(5')pppA- HeLa Cells. and m7G(5')pppG- structures referred to as caps. The reaction HeLa S3 cells were harvested from suspension culture at 3 X involves the transfer of a GMP moiety from GTP to the 5' end 105 cells per ml and washed three times with 20mM Tris-HCl of an RNA molecule containing at Teast two terminal phos- (pH 7.6)/146 mM NaCl/11 mM glucose at 4°. The cells were phates. Significantly, neither the P nor the 'y phosphates of GTP then swollen in three volumes of 20mM Tris-HC1 (pH 7.9)/10 are transferred and polynucleotides with no 5'-terminal phos- mM MgCI2/10 mM KCI/0.25 mM spermidine at 00 and dis- phate or only one are not acceptors. In the absence of methyl rupted by Dounce homogenization. An equal volume of cold donor, G(5')pppA- and G(5')pppG- structures were synthesized, indicating that methylation is not required for guanylylation. 20mM Tris.HCI (pH 7.6)/50% glycerol was immediately added Cap formation was considered to occur by the following to the lysate. -
Review Galactokinase: Structure, Function and Role in Type II
CMLS, Cell. Mol. Life Sci. 61 (2004) 2471–2484 1420-682X/04/202471-14 DOI 10.1007/s00018-004-4160-6 CMLS Cellular and Molecular Life Sciences © Birkhäuser Verlag, Basel, 2004 Review Galactokinase: structure, function and role in type II galactosemia H. M. Holden a,*, J. B. Thoden a, D. J. Timson b and R. J. Reece c,* a Department of Biochemistry, University of Wisconsin, Madison, Wisconsin 53706 (USA), Fax: +1 608 262 1319, e-mail: [email protected] b School of Biology and Biochemistry, Queen’s University Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL, (United Kingdom) c School of Biological Sciences, The University of Manchester, The Michael Smith Building, Oxford Road, Manchester M13 9PT, (United Kingdom), Fax: +44 161 275 5317, e-mail: [email protected] Received 13 April 2004; accepted 7 June 2004 Abstract. The conversion of beta-D-galactose to glucose unnatural sugar 1-phosphates. Additionally, galactoki- 1-phosphate is accomplished by the action of four en- nase-like molecules have been shown to act as sensors for zymes that constitute the Leloir pathway. Galactokinase the intracellular concentration of galactose and, under catalyzes the second step in this pathway, namely the con- suitable conditions, to function as transcriptional regula- version of alpha-D-galactose to galactose 1-phosphate. tors. This review focuses on the recent X-ray crystallo- The enzyme has attracted significant research attention graphic analyses of galactokinase and places the molecu- because of its important metabolic role, the fact that de- lar architecture of this protein in context with the exten- fects in the human enzyme can result in the diseased state sive biochemical data that have accumulated over the last referred to as galactosemia, and most recently for its uti- 40 years regarding this fascinating small molecule ki- lization via ‘directed evolution’ to create new natural and nase. -
The General Transcription Factors of RNA Polymerase II
Downloaded from genesdev.cshlp.org on October 7, 2021 - Published by Cold Spring Harbor Laboratory Press REVIEW The general transcription factors of RNA polymerase II George Orphanides, Thierry Lagrange, and Danny Reinberg 1 Howard Hughes Medical Institute, Department of Biochemistry, Division of Nucleic Acid Enzymology, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, Piscataway, New Jersey 08854-5635 USA Messenger RNA (mRNA) synthesis occurs in distinct unique functions and the observation that they can as- mechanistic phases, beginning with the binding of a semble at a promoter in a specific order in vitro sug- DNA-dependent RNA polymerase to the promoter re- gested that a preinitiation complex must be built in a gion of a gene and culminating in the formation of an stepwise fashion, with the binding of each factor promot- RNA transcript. The initiation of mRNA transcription is ing association of the next. The concept of ordered as- a key stage in the regulation of gene expression. In eu- sembly recently has been challenged, however, with the karyotes, genes encoding mRNAs and certain small nu- discovery that a subset of the GTFs exists in a large com- clear RNAs are transcribed by RNA polymerase II (pol II). plex with pol II and other novel transcription factors. However, early attempts to reproduce mRNA transcrip- The existence of this pol II holoenzyme suggests an al- tion in vitro established that purified pol II alone was not ternative to the paradigm of sequential GTF assembly capable of specific initiation (Roeder 1976; Weil et al. (for review, see Koleske and Young 1995). -
Conventional and Unconventional Mechanisms for Capping Viral Mrna
REVIEWS Conventional and unconventional mechanisms for capping viral mRNA Etienne Decroly1, François Ferron1, Julien Lescar1,2 and Bruno Canard1 Abstract | In the eukaryotic cell, capping of mRNA 5′ ends is an essential structural modification that allows efficient mRNA translation, directs pre-mRNA splicing and mRNA export from the nucleus, limits mRNA degradation by cellular 5′–3′ exonucleases and allows recognition of foreign RNAs (including viral transcripts) as ‘non-self’. However, viruses have evolved mechanisms to protect their RNA 5′ ends with either a covalently attached peptide or a cap moiety (7‑methyl-Gppp, in which p is a phosphate group) that is indistinguishable from cellular mRNA cap structures. Viral RNA caps can be stolen from cellular mRNAs or synthesized using either a host- or virus-encoded capping apparatus, and these capping assemblies exhibit a wide diversity in organization, structure and mechanism. Here, we review the strategies used by viruses of eukaryotic cells to produce functional mRNA 5′-caps and escape innate immunity. Pre-mRNA splicing The cap structure found at the 5′ end of eukaryotic reactions involved in the viral RNA-capping process, A post-transcriptional mRNAs consists of a 7‑methylguanosine (m7G) moi‑ and the specific cellular factors that trigger a response modification of pre-mRNA, in ety linked to the first nucleotide of the transcript via a from the innate immune system. which introns are excised and 5′–5′ triphosphate bridge1 (FIG. 1a). The cap has several exons are joined in order to form a translationally important biological roles, such as protecting mRNA Capping, decapping and turnover of host RNA functional, mature mRNA.